Companies › HRMY

HARMONY BIOSCIENCES HLDGS IN (HRMY)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001802665 · EDGAR filings · Updated 2026-07-28

HARMONY BIOSCIENCES HLDGS IN (HRMY) has reported institutional ownership of 96.0%, with 308 institutional managers holding positions valued at $1.56B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-28 — SCHEDULE 13G/A filed
• 2026-07-22 — Initial insider ownership filed (Form 3)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-16 — Current report (8-K) filed
• 2026-07-02 — Notice of proposed sale filed (Form 144)
• 2026-06-30 — Notice of proposed sale filed (Form 144)
• 2026-06-26 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HARMONY BIOSCIENCES HLDGS IN has 308 institutional holders and institutional ownership of 96.0%.

Insider activity

Insiders reported 34 transactions (0 buys, 9 sells) across 5 reporting insiders, with a net reported value of −$3.86M.

Data flags from SEC filings

Related companies

AMYLYX PHARMACEUTICALS INC (AMLX) · IMMUNOCORE HLDGS PLC (IMCR) · MBX BIOSCIENCES INC (MBX) · ANAPTYSBIO INC (ANAB) · MAZE THERAPEUTICS INC (MAZE) · ENOVIS CORPORATION COM (ENOV)